BRPI0417407A - derivados de 1-n-fenil-amino-1h-imidazol e composições farmacêuticas contendo estes - Google Patents

derivados de 1-n-fenil-amino-1h-imidazol e composições farmacêuticas contendo estes

Info

Publication number
BRPI0417407A
BRPI0417407A BRPI0417407-0A BRPI0417407A BRPI0417407A BR PI0417407 A BRPI0417407 A BR PI0417407A BR PI0417407 A BRPI0417407 A BR PI0417407A BR PI0417407 A BRPI0417407 A BR PI0417407A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
compositions containing
amino
phenyl
imidazole derivatives
Prior art date
Application number
BRPI0417407-0A
Other languages
English (en)
Inventor
Jean Lafay
Beno T Rondot
Paule Bonnet
Thierry Clerc
Jacqueline Shields
Igor Duc
Eric Duranti
Francois Puccio
Christian Blot
Philippe Maillos
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702365&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0417407(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP03293152A external-priority patent/EP1544195A1/en
Application filed by Theramex filed Critical Theramex
Publication of BRPI0417407A publication Critical patent/BRPI0417407A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"DERIVADOS DE 1-NFENIL-AMINO-IH-IMIDAZOL E COMPOSIçõES FARMACêUTICAS CONTENDO ESTES". O presente pedido de patente de invenção se refere aos compostos da fórmula (1), no qual R~ 1~, R~ 2~, R~ 3~, R~ 4~, Q e Z estão definidos na especificação. A invenção se refere também às composições farmacêuticas contendo estes compostos. A invenção se refere em geral ao campo do câncer hormónio-dependente e não hormónio-dependente e das desordens endócrinas.
BRPI0417407-0A 2003-12-15 2004-12-15 derivados de 1-n-fenil-amino-1h-imidazol e composições farmacêuticas contendo estes BRPI0417407A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03293152A EP1544195A1 (en) 2003-12-15 2003-12-15 1-N-phenyl-amino- 1H-imidazole derivatives and pharmaceutical compositions containing them
EP04292681 2004-11-12
PCT/EP2004/014847 WO2005058842A1 (en) 2003-12-15 2004-12-15 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
BRPI0417407A true BRPI0417407A (pt) 2007-04-03

Family

ID=34702365

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417407-0A BRPI0417407A (pt) 2003-12-15 2004-12-15 derivados de 1-n-fenil-amino-1h-imidazol e composições farmacêuticas contendo estes

Country Status (18)

Country Link
US (1) US8476455B2 (pt)
EP (1) EP1694650A1 (pt)
JP (2) JP4834557B2 (pt)
KR (1) KR20060123186A (pt)
CN (1) CN1890221B (pt)
AR (1) AR047144A1 (pt)
AU (1) AU2004299286B2 (pt)
BR (1) BRPI0417407A (pt)
CA (1) CA2549603A1 (pt)
IL (1) IL176077A0 (pt)
MA (1) MA28286A1 (pt)
MX (1) MXPA06006837A (pt)
NO (1) NO20062710L (pt)
NZ (1) NZ548399A (pt)
OA (1) OA13336A (pt)
RU (1) RU2365586C2 (pt)
TW (1) TW200533668A (pt)
WO (1) WO2005058842A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127923D0 (en) 2001-11-21 2002-01-16 Sterix Ltd Compound
EP2035405A1 (de) * 2006-07-05 2009-03-18 Merck Patent GmbH Sulfamat-benzothiophen-derivate
AU2007327943A1 (en) * 2006-12-04 2008-06-12 Merck Patent Gmbh Sulphamate benzothiophene derivatives
WO2009037539A2 (en) 2007-09-17 2009-03-26 Preglem S.A. Treatment of oestrogen dependant conditions in pre-menopausal women
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
AU2016366680B2 (en) 2015-12-09 2021-06-24 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective estrogen receptor downregulators
CN110177554B (zh) 2017-01-06 2023-06-02 G1治疗公司 用于治疗癌症的组合疗法
WO2018187414A1 (en) * 2017-04-05 2018-10-11 The Regents Of The University Of California Inhibitors of mtor-rictor interactions
WO2019241156A1 (en) * 2018-06-11 2019-12-19 Loma Linda University Methods of delaying and reversing alzheimer's disease progression

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558625A (en) * 1968-10-31 1971-01-26 Merck & Co Inc Pyrazinecarboxyaldehydes and method for their preparation
BE757186A (fr) 1969-10-07 1971-04-07 Bayer Ag Nouveaux esters d'acides pyridazino-thiono-phosphoriques et-phosphoniques, leur procede de preparation et leur application comme insecticides et acaricides
US4166452A (en) * 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4584302A (en) 1983-09-26 1986-04-22 Mcneilab, Inc. Methods for the treatment of ventricular dysrhythmia and prevention of ventricular fibrillation
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US5071861A (en) 1986-03-07 1991-12-10 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5674886A (en) * 1991-09-02 1997-10-07 Yamanouchi Pharmaceutical Co., Ltd. Triazolylated teritiary amine compound or salt thereof
JP2500849B2 (ja) * 1991-09-02 1996-05-29 山之内製薬株式会社 トリアゾリル置換３級アミノ化合物又はその塩
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
AU5121796A (en) 1995-05-08 1996-11-29 Nippon Chemiphar Co. Ltd. 2,4-thiazolidinedione or oxazolidinedione derivatives and hy poglycemic agent
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
JP4320089B2 (ja) * 1999-07-06 2009-08-26 あすか製薬株式会社 フェニルスルファメート誘導体
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
US7045539B2 (en) 2000-12-22 2006-05-16 Astrazeneca Ab Therapeutic benzoxazole compounds
JP2004519477A (ja) * 2001-02-23 2004-07-02 カー・イュー・ルーベン・リサーチ・アンド・ディベロップメント Ｈｉｖ抑制ｎ−アミノイミダゾール誘導体
CN1370533A (zh) 2001-02-27 2002-09-25 中国人民解放军军事医学科学院放射医学研究所 一类新的苯并噻吩类化合物在防治妇女绝经后综合症和其它与雌激素相关疾病中的用途
US7109193B2 (en) * 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
WO2003045925A1 (en) * 2001-11-21 2003-06-05 Sterix Limited 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
GB0127923D0 (en) * 2001-11-21 2002-01-16 Sterix Ltd Compound
US7440571B2 (en) * 2002-12-03 2008-10-21 Nagravision S.A. Method for securing software updates
EP1431292A1 (en) 2002-12-16 2004-06-23 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors
JP2004196795A (ja) * 2002-12-16 2004-07-15 Wyeth 外部寄生虫駆除剤としてのｎ−フェニル−３−シクロプロピルピラゾール−４−カルボニトリル
EP1644350B1 (en) 2003-05-16 2009-07-01 Laboratoire Theramex Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors

Also Published As

Publication number Publication date
NO20062710L (no) 2006-06-30
AU2004299286A1 (en) 2005-06-30
WO2005058842A1 (en) 2005-06-30
JP2007515420A (ja) 2007-06-14
EP1694650A1 (en) 2006-08-30
NZ548399A (en) 2011-01-28
US20070112009A1 (en) 2007-05-17
TW200533668A (en) 2005-10-16
AR047144A1 (es) 2006-01-11
MA28286A1 (fr) 2006-11-01
MXPA06006837A (es) 2006-09-04
RU2006125417A (ru) 2008-01-27
OA13336A (en) 2006-04-13
US8476455B2 (en) 2013-07-02
JP5209760B2 (ja) 2013-06-12
KR20060123186A (ko) 2006-12-01
CN1890221A (zh) 2007-01-03
CN1890221B (zh) 2014-07-16
JP2011190277A (ja) 2011-09-29
IL176077A0 (en) 2006-10-05
RU2365586C2 (ru) 2009-08-27
CA2549603A1 (en) 2005-06-30
JP4834557B2 (ja) 2011-12-14
AU2004299286B2 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
TW200609235A (en) Tetraazabenzo[e]azulene derivatives and analogs thereof
BRPI0511102A (pt) beta-agonistas enantiÈmeros puros, processos para sua produção e seu uso como medicamento
CY1116372T1 (el) Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη
BR0211473A (pt) Novos compostos
CY1108592T1 (el) Διϋδροτετραβεναζινες και φαρμακευτικες συνθεσεις που τις περιεχουν
IL184872A0 (en) Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
MY144634A (en) 3-or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
BR9707064A (pt) Novos derivados 19-nor-pregneno
DK1819227T3 (da) Farmaceutisk formulering af decitabin
BR0211472A (pt) Novos compostos
BRPI0417708A (pt) derivados organofosfóricos dos indazóis e sua utilização como inibidores das proteìnas quinases
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
SE0302760D0 (sv) New compounds
BRPI0407734A (pt) derivados de adamantano, processo para sua preparação e composições farmacêuticas os contendo
HRP20140439T1 (hr) Sredstvo protiv tumora
BRPI0417407A (pt) derivados de 1-n-fenil-amino-1h-imidazol e composições farmacêuticas contendo estes
CR8371A (es) Formulaciones de medicamento que contienen saborizantes con mejores propiedades farmaceuticas
BR0311984A (pt) Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação
MA27610A1 (fr) Derives d'acylaminothiazole, leur preparation et leur utilisation en tant qu'inhibiteurs de la production du peptide beta-amyloide
SE0400708D0 (sv) New compounds and use thereof
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos
MXPA06000636A (es) Formulaciones semi-solidas para la administracion oral de taxoides.
SE0101978D0 (sv) New compounds
TW200633987A (en) Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]